Caption Management, LLC Spectrum Pharmaceuticals Inc Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $24,177 - $45,581	-13,212 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$3.5 - $10.35 $9,758 - $28,855	-2,788 Reduced 17.42%	13,212 $48,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $112,480 - $155,200	16,000 New	16,000 $132,000
Q4 2018 Jan 30, 2019	SELL	$6.39 - $16.99 $19,170 - $50,969	-3,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $49,560 - $74,460	3,000 New	3,000 $50,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.